comparemela.com

PETALUMA, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies Inc. (OTCQB:RTGN) (“ RetinalGeniX ” or the “Company”) today announced that it has been granted a patent by the United

Related Keywords

United States , Jerry Katzman , Technologies Inc , Retinalgenix Technologies Inc , Company Annual Report On Form , United States Patent , Trademark Office , Cystic Fibrosis , Private Securities Litigation Reform Act , Annual Report , Genix Technologies , Region ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.